Research shaping
the future of
neuroscience

FIND OUT MORE

Specialist clinics
improving
quality of life

FIND OUT MORE

Parkinson’s Research

The objective of the Perron Institute’s Parkinson’s Research, led by Clinical Professor Soumya Ghosh, Professor Frank Mastaglia and Clinical Professor Michelle Byrnes, is to better understand Parkinson’s, the markers of disease progression and the causative factors to improve management and quality of life of people living with Parkinson’s.

Parkinson’s is a chronic neurodegenerative disease second only to Alzheimer’s disease in its global prevalence. Despite being widespread and affecting many individuals, very little is known about what factors cause Parkinson’s, with considerable variation in the age that symptoms commence, how rapidly it progresses and how people respond to treatment.

Research Focus

At present, very little is known about Parkinson’s and studies unveiling factors contributing to the disease, or biomarkers of the disease are necessary. To this end, the Parkinson’s Disease Research being conducted at the Perron Institute aim to:

  • Study how genes, treatments, the environment and clinical features influence the cause progression and course of Parkinson’s.
  • Identify early biomarkers of Parkinson’s, of cognitive decline in Parkinson’s and of impulse control disorders in Parkinson’s.
  • Study patient demographics and possible underlying risk factors influencing the cognitive decline and/or development of impulse control disorders in Parkinson’s.
  • Create a bio-bank of Parkinson’s patient data and control data for future researchers and research methods.
  • Maintain the Parkinson’s Disease Registry.

Members

Megan Bakeberg

Jade Kenna

Maddeson Riley

Alexa Jefferson

Achievements

PUBLICATIONS

2018

Maddeson Riley, Megan Bakeberg, Michelle Byrnes, Alexa Jefferson, Soumya Ghosh, Rick Stell, Frank L. Mastaglia, Dana Hince, and Ryan S. Anderton. Demographic and Clinical Predictors of Trait Impulsivity in Parkinson’s Disease Patients. DOI:10.1155/2018/9472120

GRANTS